Daily Financial News
FNArena is one of few remaining truly independent providers of financial markets analysis, financial commentary and business news in Australia. Our Daily Financial News is not based on ASX lodgements or corporate press releases, but more so on updated views, insights and responses from stockbrokers and other experts. FNArena is not aligned with any financial institution, hence the moniker “independent”. We have a long history of publishing out-of-consensus views and market analysis. Our quest is not to be bullish or bearish, but to correctly assess future trends.
Oct 10 2019 - Commodities
Ahead of the Herd’s Rick Mills asks for how long can the US keep increasing its debt, and what asset class provides a hedge?
Oct 09 2019 - Australia
Specialist fund platforms continue to benefit from disruption, taking business from the majors, but brokers point out a squeeze on cash accounts looms large amid further cuts to official interest rates.
Oct 09 2019 - Small Caps
Baby Bunting has confidently reiterated earnings assumptions for FY20, with an expanded gross margin being the main surprise in a detailed trading update at the AGM.
Oct 08 2019 - Small Caps
EclipX Group is reverting to focus on its core fleet and novated leasing businesses, and interest in the company is only expected to grow.
Oct 08 2019 - Treasure Chest
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. NextDC has defied the critics so far, with sales in excess of what can be delivered and the next two years of operating earnings growth supported by existing contracts.
Oct 08 2019 - Technicals
Michael Gable of Fairmont Equities suggest the long downturn in the Domino’s Pizza share price may have come to an end.
Oct 04 2019 - Australia
As a record low cash rate prevails, amid weak consumer and business sentiment and only muted improvements in housing activity, Australia’s major banks are being squeezed mercilessly.
Oct 03 2019 - Australia
A new specialty female oral contraceptive will grace the portfolio of Mayne Pharma, providing a substantial growth opportunity in the medium-long term.
Oct 03 2019 - Technicals
The Chartist suggests recent consolidation for the iron ore price implies risk remains to the upside.
Oct 03 2019 - FYI
The New Criterion’s Tim Boreham notes massive legal settlements in the US have highlighted the scourge of opioid abuse, but Australian producer Palla Pharma is confident the drug class will remain the world’s foremost pain medication.
2:05 PM - Commodities
12:22 PM - Feature Stories
11:56 AM - Small Caps
10:28 AM - Technicals
10:00 AM - Weekly Reports
Sep 27 2019 - Rudi's View
Sep 23 2019 - Commodities
Oct 15 2019 - Weekly Reports
Oct 01 2019 - Technicals
Oct 01 2019 - Weekly Reports
Sep 30 2019 - Australia